Literature DB >> 18950306

Noninvasive imaging in cardiac resynchronization therapy--part 1: selection of patients.

Claudia Ypenburg1, Jos J Westenberg, Gabe B Bleeker, Nico VAN de Veire, Nina A Marsan, Maureen M Henneman, Ernst E van der Wall, Martin J Schalij, Theodore P Abraham, S Serge Barold, Jeroen J Bax.   

Abstract

Cardiac resynchronization therapy (CRT) is an established therapy for patients with advanced heart failure, depressed left ventricular function, and wide QRS complex. However, individual response varies, and a substantial amount of patients do not respond to CRT. Recent studies observed that assessment of inter- and particularly intraventricular dyssynchrony may allow identification of potential responders to CRT. In addition, presence of scar tissue and venous anatomy may play a role in the selection of candidates. In this review, an extensive overview of the available dyssynchrony measurements is provided using echocardiography as well as magnetic resonance imaging (MRI) and nuclear imaging. Furthermore, other information derived from MRI, nuclear imaging, and computed tomography useful for the selection of potential candidates for CRT will be discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18950306     DOI: 10.1111/j.1540-8159.2008.01212.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  25 in total

1.  Assessment of the coronary venous system in heart failure patients by blood pool agent enhanced whole-heart MRI.

Authors:  Robert Manzke; Ludwig Binner; Axel Bornstedt; Nico Merkle; Anja Lutz; Robert Gradinger; Volker Rasche
Journal:  Eur Radiol       Date:  2010-09-26       Impact factor: 5.315

Review 2.  [Cardiac resynchronization therapy: preoperative screening. How can we reliably predict response to CRT?].

Authors:  M Kindermann; F Mahfoud; C Ukena; G Fröhlig
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2009-09

Review 3.  Role of cardiac MRI and nuclear imaging in cardiac resynchronization therapy.

Authors:  Niti R Aggarwal; Matthew W Martinez; Bernard J Gersh; Panithaya Chareonthaitawee
Journal:  Nat Rev Cardiol       Date:  2009-11-03       Impact factor: 32.419

Review 4.  Clinical, laboratory, and pacing predictors of CRT response.

Authors:  Jagdesh Kandala; Robert K Altman; Mi Young Park; Jagmeet P Singh
Journal:  J Cardiovasc Transl Res       Date:  2012-02-24       Impact factor: 4.132

5.  Validation of electromechanical wave imaging in a canine model during pacing and sinus rhythm.

Authors:  Julien Grondin; Alexandre Costet; Ethan Bunting; Alok Gambhir; Hasan Garan; Elaine Wan; Elisa E Konofagou
Journal:  Heart Rhythm       Date:  2016-08-04       Impact factor: 6.343

Review 6.  Profiling cardiac resynchronization therapy patients: responders, non-responders and those who cannot respond--the good, the bad and the ugly?

Authors:  Valerio Zacà; Sergio Mondillo; Rosaria Gaddi; Roberto Favilli
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-17       Impact factor: 2.357

7.  Significance of signal averaged electrocardiography in patients with advanced heart failure and intraventricular conduction delay.

Authors:  Mohammad Alasti; Majid Haghjoo; Abolfath Alizadeh; Mohammad Hossein Nikoo; Hamid Reza Bonakdar; Bita Omidvar; Ali Kharazi; Bahman Cheraghian
Journal:  Indian Pacing Electrophysiol J       Date:  2010-05-05

8.  Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism.

Authors:  E E van der Wall; M J Schalij; A van der Laarse; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-12       Impact factor: 2.357

9.  Cardiac resynchronization therapy; evaluation by advanced imaging techniques.

Authors:  E E van der Wall; M J Schalij; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-29       Impact factor: 2.357

10.  Volumetric motion quantification by 3D tissue phase mapped CMR.

Authors:  Anja Lutz; Jan Paul; Axel Bornstedt; G Ulrich Nienhaus; Patrick Etyngier; Peter Bernhardt; Wolfgang Rottbauer; Volker Rasche
Journal:  J Cardiovasc Magn Reson       Date:  2012-10-26       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.